EVGN - Evogene Ltd.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
2.2350
-0.0550 (-2.40%)
As of 3:40PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close2.2900
Open2.2400
Bid2.2100 x 1800
Ask2.2400 x 900
Day's Range2.2050 - 2.2400
52 Week Range1.6700 - 3.4600
Volume22,377
Avg. Volume32,967
Market Cap55.205M
Beta (3Y Monthly)1.62
PE Ratio (TTM)N/A
EPS (TTM)-0.8060
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.00
Trade prices are not sourced from all markets
  • Biomica Initiates Pre-clinical Studies in Its Immuno-oncology Program
    PR Newswire7 days ago

    Biomica Initiates Pre-clinical Studies in Its Immuno-oncology Program

    Aims to augment current cancer therapies by altering patients' gut microbiome to improve response REHOVOT, Israel , April 16, 2019 /PRNewswire/ -- Biomica, an emerging biopharmaceutical company developing ...

  • Market Exclusive19 days ago

    Cannabis Stock News Daily Roundup April 4

    Planet 13 Holdings (CSE: PLTH) (OTCQB: PLNHF) has launched its third wholly-owned brand Leaf & Vine, a line of chic disposable vape and concentrate products. Liberty Health Sciences (CSE: LHS) (OTCQX: LHSIF) is opening its 13th Florida dispensary in Bonita Springs on April 5. The 4,000-square-foot facility is located at 24611 Production Circle Bonita Springs, Bonita Springs. Pure Global Cannabis (TSX.V: […]The post Cannabis Stock News Daily Roundup April 4 appeared first on Market Exclusive.

  • Benzinga20 days ago

    Agribiotech Evogene Launches Medical Cannabis Subsidiary, CEO Expects 'Significant Impact' In Sector

    It's not unusual these days to see agri-tech and biotech stocks jumping on the cannabis bandwagon to capitalize on the opportunity presented by the geographically expanding legalization of pot. What Happened ...

  • Evogene to Develop Next Generation Medical Cannabis Products Through New Subsidiary - Canonic Ltd
    PR Newswire20 days ago

    Evogene to Develop Next Generation Medical Cannabis Products Through New Subsidiary - Canonic Ltd

    REHOVOT, Israel, April 3, 2019 /PRNewswire/ -- Evogene Ltd. (EVGN) (EVGN), a leading biotechnology company developing novel products for life science markets, announced today that it has established a new subsidiary – Canonic Ltd – to develop next generation medical cannabis products. Evogene has been evaluating the medical cannabis field for more than a year, including market evaluation, obtaining governmental approvals for its research program and the establishment of a research facility, technology assessment and initial product line planning.

  • AgPlenus - Evogene's Ag-Chemicals Subsidiary - Announces the Nomination of Three Industry Leaders From the Field of Crop Protection to Its Board of Directors
    PR Newswirelast month

    AgPlenus - Evogene's Ag-Chemicals Subsidiary - Announces the Nomination of Three Industry Leaders From the Field of Crop Protection to Its Board of Directors

    REHOVOT, Israel, March 14, 2019 /PRNewswire/ -- AgPlenus, a subsidiary of Evogene Ltd. (EVGN) (EVGN), designing effective and sustainable crop protection products by leveraging predictive biology, announced today the nomination of leading industry experts from the field of chemical crop protection to its board of directors. The nominated board is expected to support the company in executing its business strategy. Dr. Percy most recently held the position of Head of Research & Development for the Crop Science division of Bayer and member of its Executive Committee.

  • Evogene to Participate in the World Agritech, Innovation Summit in San Francisco in March 19-20, 2019
    PR Newswirelast month

    Evogene to Participate in the World Agritech, Innovation Summit in San Francisco in March 19-20, 2019

    Ido Dor, CEO of Lavie Bio, will participate in a panel on Ag-Biologicals; in addition, Eran Kosover, CEO of AgPlenus will host a round table on collaborations in the field REHOVOT, Israel , March 1 4 , ...

  • Associated Presslast month

    Evogene: 4Q Earnings Snapshot

    The Rehovot, Israel-based company said it had a loss of 23 cents per share. The agricultural company posted revenue of $635,000 in the period. For the year, the company said its loss was nearly unchanged ...

  • Evogene Reports Fourth Quarter and Full Year 2018 Financial Results
    PR Newswirelast month

    Evogene Reports Fourth Quarter and Full Year 2018 Financial Results

    Conference call and webcast, today at 9:00 am Eastern Time REHOVOT, Israel , March 13, 2019 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company developing novel products ...

  • Evogene Fourth Quarter and Full Year of 2018 Earnings Announcement Schedule
    PR Newswire2 months ago

    Evogene Fourth Quarter and Full Year of 2018 Earnings Announcement Schedule

    REHOVOT, Israel , Feb. 28, 2019 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today that it will ...

  • Evogene Announces Establishment of Ag-Biologicals Subsidiary - LaVie Bio Ltd.
    PR Newswire2 months ago

    Evogene Announces Establishment of Ag-Biologicals Subsidiary - LaVie Bio Ltd.

    Evogene's activities relating to discovery, optimization and development of sustainable ag-biological products are being transferred to the new subsidiary REHOVOT, Israel , Feb. 26, 2019 /PRNewswire/ -- ...

  • Evogene Appoints Dr. Adrian Percy to Its Board of Directors
    PR Newswire3 months ago

    Evogene Appoints Dr. Adrian Percy to Its Board of Directors

    REHOVOT, Israel, Feb. 4, 2019 /PRNewswire/ -- Evogene Ltd. (EVGN) (EVGN), a leading biotechnology company developing novel products for life science markets, announced today the appointment of Dr. Adrian Percy to its board of directors. Dr. Percy has more than 25 years of experience in the agricultural industry and is a strong advocate of the critical need for new environmentally friendly agricultural and food technologies to support global food supply and security.

  • GlobeNewswire4 months ago

    Evogene and TMG Announce Collaboration to Develop Nematode Resistant Soybean through Genome Editing

    Pursuant to the collaboration, Evogene will utilize its CPB (Computational Predictive Biology) platform to identify the required genome edits to attribute nematode resistance in soybean and will perform such edits on TMG’s proprietary commercial soybean germplasm. TMG will validate the efficacy of the edited soybeans in greenhouse assays and in field trials in Brazil and will incorporate the edited genes in TMG breeding pipeline.

  • GlobeNewswire5 months ago

    Evogene’s Leading Insect Control Genes Demonstrate Effectiveness Against Insects with Resistance to Current Commercial Solutions

    Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announces today that a well-recognized external laboratory and in-house testing had confirmed that leading Evogene insect control genes demonstrated efficacy against insects with resistance to current commercial insect control products, including fall armyworm and diamondback moth.

  • GlobeNewswire5 months ago

    AgPlenus, a subsidiary of Evogene, to Present at the 2nd Annual AgChem & Technology Europe Conference

    REHOVOT, Israel, Nov. 19, 2018 -- AgPlenus, a fully owned subsidiary of Evogene Ltd. (NASDAQ, TASE: EVGN), an innovative company aiming to discover, develop and bring to the.

  • GlobeNewswire5 months ago

    Evogene Announces Establishment of Ag-Chemicals Subsidiary – AgPlenus Ltd.

    REHOVOT, Israel, Nov. 19, 2018 (GLOBE NEWSWIRE) --  Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today the establishment of a new subsidiary – AgPlenus Ltd.  All of Evogene’s ag-chemical activities focusing on the design and development of effective and safe next generation agro-chemical products are being transferred to the new subsidiary, along with access to Evogene’s Computational Predictive Biology (“CPB”) platform. The ag-chemical activities being transferred to AgPlenus, which were initiated in 2014, now consist of a substantial internal and collaborative product pipeline focusing on herbicides and insecticides with a clear go-to-market strategy.

  • Associated Press5 months ago

    Evogene: 3Q Earnings Snapshot

    On a per-share basis, the Rehovot, Israel-based company said it had a loss of 19 cents. The agricultural company posted revenue of $367,000 in the period. The company's shares closed at $2.73. A year ago, ...

  • GlobeNewswire5 months ago

    Evogene Reports Third Quarter 2018 Financial Results

    REHOVOT, Israel, Nov. 14, 2018 -- Conference call and webcast, today at 9:00 am Eastern Time Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing.

  • GlobeNewswire6 months ago

    Biomica Announces the Addition of Internationally Renowned Experts in the Fields of Gastroenterology and the Human Microbiome to its Scientific Advisory Board

    REHOVOT, Israel, Nov. 06, 2018 (GLOBE NEWSWIRE) --  Biomica, a subsidiary of Evogene Ltd. (NASDAQ, TASE: EVGN), an emerging biopharmaceutical company developing innovative microbiome-based therapeutics announced today that internationally renowned experts have joined the company’s scientific advisory board. The experts will join Prof. Yehuda Ringel, Biomica co-founder and CSO, an internationally recognized thought leader in the field of the functional gastrointestinal disorders and the intestinal microbiome, in order to support the company’s upcoming steps towards its clinical development. Prof. Willem M De Vos is Professor and Chair of Microbiology at Wageningen University, the Netherlands and Professor of Human Microbiomics at the University of Helsinki, Finland, where he also served as Finland Distinguished and Academy Professor.

  • Associated Press8 months ago

    Evogene: 2Q Earnings Snapshot

    On a per-share basis, the Rehovot, Israel-based company said it had a loss of 19 cents. The agricultural company posted revenue of $379,000 in the period. The company's shares closed at $2.88. A year ago, ...

  • ACCESSWIRE8 months ago

    Evogene Ltd to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Evogene Ltd (NASDAQ: EVGN ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 9:00 AM Eastern Time. To listen ...